TET2 and angioimmunoblastic T-cell lymphoma: CD28 (9.4–11.3%), DNMT3A (20–30%), IDH2 (20–45%), TET2 (47–83%), and RHOA mutations (50–70%) are the most common genetic alterations detected in AITL.